Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Finally A Victory For K-V Pharmaceutical’s Orphan Drug Makena August 10, 2012 Finally a victory for K-V Pharmaceutical’s orphan drug Makena. A Georgia U.S. District Judge orders the state to provide Medicaid coverage for Makena.
Per the Judge, Makena has FDA approval and the compounded version of Makena doesn’t have FDA approval. “Because the court finds that the FDA drug approval process means something,” the Judge wrote, “the state has an upside-down policy because it is covering a drug that is not FDA-approved and not covering one that is.”
References
The Atlanta Journal-Constitution August 10, 2012 Article
2 comments:
Finally A Victory For K-V Pharmaceutical’s Orphan Drug Makena
August 10, 2012
Finally a victory for K-V Pharmaceutical’s orphan drug Makena. A Georgia U.S. District Judge orders the state to provide Medicaid coverage for Makena.
Per the Judge, Makena has FDA approval and the compounded version of Makena doesn’t have FDA approval. “Because the court finds that the FDA drug approval process means something,” the Judge wrote, “the state has an upside-down policy because it is covering a drug that is not FDA-approved and not covering one that is.”
References
The Atlanta Journal-Constitution August 10, 2012 Article
Thank you for update and post.
Post a Comment